CDKN2A and neoplasm: For the other key driver genes for PDAC, the mutation frequency of CDKN2A was 21% in both the tumor and blood samples, with high mutation abundance observed in 12% of both samples, and the mutation frequency of SMAD4 was 16% in both the tumor and ctDNA samples, with high mutation abundance seen in 7% of both samples.